# Virax Biolabs Group (VRAX) — Overview

VRAX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/vrax

## Price

Last close $1.67 on Oct 15, 2026. 52-week range $1.65 – $17.20.

## Company profile

Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on post-acute infection syndromes (PAIS) and related areas of chronic immune dysfunction. The company's principal development activities are centered on T cell-based in vitro diagnostics and immune profiling. The company's flagship product candidate, ViraxImmune, is an in-development T cell-based assay and immune profiling platform intended to support the assessment of immune dysfunction, initially in PAIS indications.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $12,423.00 |
| Revenue (quarter) | $12,423.00 |
| Revenue growth (year over year) | 96.22% |
| Gross profit (trailing twelve months) | $7,690.00 |
| Gross margin | 61.90% |
| Net income (trailing twelve months) | −$5.0M |
| Net income (quarter) | −$5.0M |
| Net income growth (year over year) | 17.06% |
| Net margin | -40507.00% |
| Return on equity | -75.70% |
| EPS (trailing twelve months) | −$12.64 |
| Book value per share | $25.52 |
| P/E (trailing twelve months) | — |
| Price to book | 0.3 |
| Debt to assets | 11.89% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Virax Biolabs Group (VRAX) profitable?

No. Virax Biolabs Group reported a net loss of $5.0M over the trailing twelve months.

### How much revenue does Virax Biolabs Group (VRAX) make?

Virax Biolabs Group generated $12,423.00 in revenue over the trailing twelve months, up 96.22% year over year.

### How do I buy stock in Virax Biolabs Group (VRAX)?

VRAX trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).